206 related articles for article (PubMed ID: 30362638)
21. PIWI-interacting RNAs in human cancer.
Lin Y; Zheng J; Lin D
Semin Cancer Biol; 2021 Oct; 75():15-28. PubMed ID: 32877760
[TBL] [Abstract][Full Text] [Related]
22. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in Ovarian Cancer.
Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
[TBL] [Abstract][Full Text] [Related]
23. Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer.
Vychytilova-Faltejskova P; Stitkovcova K; Radova L; Sachlova M; Kosarova Z; Slaba K; Kala Z; Svoboda M; Kiss I; Vyzula R; Cho WC; Slaby O
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1019-1028. PubMed ID: 29976566
[No Abstract] [Full Text] [Related]
24. PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.
Fu A; Jacobs DI; Hoffman AE; Zheng T; Zhu Y
Carcinogenesis; 2015 Oct; 36(10):1094-102. PubMed ID: 26210741
[TBL] [Abstract][Full Text] [Related]
25. Serum PIWI-Interacting RNAs piR-020619 and piR-020450 Are Promising Novel Biomarkers for Early Detection of Colorectal Cancer.
Wang Z; Yang H; Ma D; Mu Y; Tan X; Hao Q; Feng L; Liang J; Xin W; Chen Y; Wu Y; Jia Y; Zhao H
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):990-998. PubMed ID: 32066615
[TBL] [Abstract][Full Text] [Related]
26. PIWI Proteins and PIWI-Interacting RNA: Emerging Roles in Cancer.
Han YN; Li Y; Xia SQ; Zhang YY; Zheng JH; Li W
Cell Physiol Biochem; 2017; 44(1):1-20. PubMed ID: 29130960
[TBL] [Abstract][Full Text] [Related]
27. piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1.
Yin J; Jiang XY; Qi W; Ji CG; Xie XL; Zhang DX; Cui ZJ; Wang CK; Bai Y; Wang J; Jiang HQ
Cancer Sci; 2017 Sep; 108(9):1746-1756. PubMed ID: 28618124
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
[TBL] [Abstract][Full Text] [Related]
29. Piwi-Interacting RNAs (piRNAs) Are Dysregulated in Renal Cell Carcinoma and Associated with Tumor Metastasis and Cancer-Specific Survival.
Li Y; Wu X; Gao H; Jin JM; Li AX; Kim YS; Pal SK; Nelson RA; Lau CM; Guo C; Mu B; Wang J; Wang F; Wang J; Zhao Y; Chen W; Rossi JJ; Weiss LM; Wu H
Mol Med; 2015 May; 21(1):381-8. PubMed ID: 25998508
[TBL] [Abstract][Full Text] [Related]
30. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
31. [Involvement of PIWI-interacting RNAs in Cancerogenesis via the Regulation of Gene Expression].
Rybecká S; Štítkovcová K; Vychytilová-Faltejsková P; Slabý O
Klin Onkol; 2016; 29(6):428-438. PubMed ID: 27951720
[TBL] [Abstract][Full Text] [Related]
32. A secondary structure within a human piRNA modulates its functionality.
Balaratnam S; Hettiarachchilage M; West N; Piontkivska H; Basu S
Biochimie; 2019 Feb; 157():72-80. PubMed ID: 30414834
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting RRM2 to enhance the anticancer activity of chemotherapy.
Zhan Y; Jiang L; Jin X; Ying S; Wu Z; Wang L; Yu W; Tong J; Zhang L; Lou Y; Qiu Y
Biomed Pharmacother; 2021 Jan; 133():110996. PubMed ID: 33227712
[TBL] [Abstract][Full Text] [Related]
34. Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma.
Kang W; Tong JH; Chan AW; Zhao J; Wang S; Dong Y; Sin FM; Yeung S; Cheng AS; Yu J; To K
Oncol Rep; 2014 Jun; 31(6):2579-86. PubMed ID: 24756820
[TBL] [Abstract][Full Text] [Related]
35. Role of PIWI-interacting RNAs on cell survival: Proliferation, apoptosis, and cycle.
Zeng Q; Wan H; Zhao S; Xu H; Tang T; Oware KA; Qu S
IUBMB Life; 2020 Sep; 72(9):1870-1878. PubMed ID: 32697419
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism of piRNA in bisphenol A-promoted invasion and migration of prostate cancer cells].
Ben S; Fan LL; Cheng YF; Cheng G; Li SW; Wang ML
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Sep; 57(9):1440-1446. PubMed ID: 37743306
[No Abstract] [Full Text] [Related]
37. Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma.
Das B; Jain N; Mallick B
Gene; 2022 Jan; 808():145988. PubMed ID: 34624457
[TBL] [Abstract][Full Text] [Related]
38. piR-651 and its function in 95-D lung cancer cells.
Yao J; Wang YW; Fang BB; Zhang SJ; Cheng BL
Biomed Rep; 2016 May; 4(5):546-550. PubMed ID: 27123245
[TBL] [Abstract][Full Text] [Related]
39. Potential roles of PIWI-interacting RNAs in breast cancer, a new therapeutic strategy.
Zhang H; Li Y
Pathol Res Pract; 2024 May; 257():155318. PubMed ID: 38688203
[TBL] [Abstract][Full Text] [Related]
40. PIWI-interacting RNAs as novel regulators of pancreatic beta cell function.
Henaoui IS; Jacovetti C; Guerra Mollet I; Guay C; Sobel J; Eliasson L; Regazzi R
Diabetologia; 2017 Oct; 60(10):1977-1986. PubMed ID: 28711973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
